A 44-amino-acid synthetic GHRH analog (CAS 218949-48-5) with an N-terminal trans-3-hexenoyl moiety that resists DPP-4 cleavage and extends plasma half-life relative to native GHRH. Agonizes the GHRH receptor to stimulate physiologic pulsatile GH secretion without super-physiologic IGF-1 overshoot. FDA-approved by Theratechnologies as Egrifta / Egrifta SV for reduction of excess abdominal fat in HIV-associated lipodystrophy — the only GHRH analog currently available as an approved drug in the US.
For research purposes only. Not medical advice.
Sunrise Bioresearch currently lists Tesamorelin at $4.10/mg, the lowest indexed price across 21 tracked research peptide vendors.
Tesamorelin ranges from $4.10/mg to $14.00/mg across 36 listings from 21 research peptide vendors, normalized to USD per milligram and refreshed daily.
21 research peptide vendors currently list Tesamorelin on PeptideScouter, with 16 in stock right now. We track 36 active listings across size and kit variants.
Tesamorelin's CAS Registry Number is 218949-48-5. It is also sold as Tesa, Tesamorlin.